The use of synthesized mammography instead of additional full-field digital mammography has no significant effect on biopsy rate.
Synthesized mammography (SM) with digital breast tomosynthesis (DBT) lowers recall rate, according to a study published in the journal Academic Radiology.
Researchers from Johns Hopkins University in Baltimore, Md., and the University of Wisconsin in Madison sought to evaluate the screening performance of DBT combined with SM versus combined with full-field digital mammography (FFDM).
The researchers retrospectively reviewed 7,745 screening studies utilizing FFDM plus DBT and 14,776 with SM plus DBT. They compared recall rate, biopsy rate, positive predictive value 1 (PPV1), positive predictive value 3 (PPV3), and cancer detection rate (CDR) between the two groups.
The results showed the overall recall rate was 7.06 percent in the SM + DBT cohort, which was significantly lower compared to 7.63 percent in the FFDM + DBT cohort. There was no difference in biopsy rate, PPV1, PPV3, or CDR between the two groups.
The researchers concluded that their findings support the use of SM for patients undergoing screening with DBT.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.